Formulations of bendamustine | Patent Number 09265831

US 09265831 B2
Application Number14031879
Publication NumberUS 20140024691 A1
Pendency2 years, 5 months, 7 days
Filled DateSep 19, 2013
Priority DateJan 28, 2010
Publication DateJan 23, 2014
Expiration DateJan 27, 2030
Inventor/ApplicantsNagesh R. Palepu
Philip Christopher Buxton
ExaminesAKHOON, KAUSER M
Art Unit1642
Technology Center1600
Assignments
Jpmorgan Chase Bank
Current
Eagle Pharmaceuticals Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.